Pfizer will select more than 4,500 children from the United States, Finland, Poland and Spain for the clinical trial.
America’s leading pharmaceutical company Pfizer, which makes Corona Vaccine, has said that it will start trials of its vaccine on children under the age of 12, under which in the first phase of the study. A small number of young children will be given different doses of the vaccine. For this, Pfizer will select more than 4,500 children across more than 90 clinical sites in four countries – the United States, Finland, Poland and Spain.
The company said that the vaccine trial (Covid vaccine T)rial) For this, the work of enrolling children of 5 to 11 years will be started this week. These children will be given two doses of 10 micrograms, which is a third of the vaccine dose given to adolescents and adults. After a few weeks, the vaccine trial will be started on children above 6 months of age and they will be given three micrograms of vaccine.
A Pfizer spokesperson said that the company expects to have data for children ages 5 to 11 by September, while data for children ages 2 to 5 may come soon, after which the company will apply for emergency use. . In the US and the European Union, Pfizer’s vaccine has already been approved for children over the age of 12, although this approval has been given for emergency use only. Children of this age group are being given the same dosage as adults i.e. 30 micrograms.
Moderna is also testing the vaccine on 12 to 17 year old children
Pfizer has developed the Corona vaccine in collaboration with its German partner BioNtech. Pfizer conducted a clinical trial in March on children aged 12 to 15 years. The European Medical Association and Britain’s drug regulatory body have reviewed the data of this trial. The European Union’s drug regulatory body had said that this vaccine has not seen any serious side effects on children. Apart from Pfizer, Moderna is also conducting vaccine tests on children aged 12 to 17 years and its results may also come out soon.
read this also – Vaccine shortage again in Delhi, Covaxin dose over for people above 45 years – Atishi Marlena
read this also – WHO also approved China’s second corona vaccine, when will Covaxin get approval?